X T L Biopharmaceuticals reported $8.55M in Assets for its fiscal quarter ending in December of 2024.





Assets Change Date
Alaunos Therapeutics USD 3.72M 1.01M Sep/2025
Bioline Rx USD 39.8M 3.47M Sep/2025
Teva Pharmaceutical Industries USD 40.75B 892M Dec/2025
X T L Biopharmaceuticals USD 8.55M 730K Dec/2024